Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 64 | 2019 | 494 | 12.480 |
Why?
|
Aging | 40 | 2017 | 881 | 6.630 |
Why?
|
Muscle Fibers, Skeletal | 28 | 2019 | 104 | 5.450 |
Why?
|
Calcium | 34 | 2015 | 296 | 4.840 |
Why?
|
Calcium Channels, L-Type | 32 | 2016 | 45 | 4.470 |
Why?
|
Pericytes | 10 | 2017 | 28 | 4.270 |
Why?
|
Muscle Contraction | 27 | 2019 | 114 | 4.120 |
Why?
|
Insulin-Like Growth Factor I | 20 | 2011 | 80 | 3.690 |
Why?
|
Calcium Channels | 23 | 2019 | 56 | 3.380 |
Why?
|
Mice | 56 | 2019 | 2368 | 2.760 |
Why?
|
Troponin T | 7 | 2018 | 57 | 2.690 |
Why?
|
Animals | 93 | 2019 | 7297 | 2.520 |
Why?
|
Sarcoplasmic Reticulum | 15 | 2015 | 15 | 2.310 |
Why?
|
Muscle Strength | 11 | 2019 | 139 | 2.120 |
Why?
|
Muscle Fibers, Fast-Twitch | 10 | 2017 | 29 | 1.800 |
Why?
|
Resistance Training | 4 | 2019 | 70 | 1.780 |
Why?
|
Motor Neurons | 10 | 2018 | 53 | 1.580 |
Why?
|
Calcium Signaling | 7 | 2013 | 40 | 1.570 |
Why?
|
Muscle Fibers, Slow-Twitch | 8 | 2016 | 20 | 1.530 |
Why?
|
Cell Nucleus | 5 | 2018 | 105 | 1.400 |
Why?
|
Neuromuscular Junction | 8 | 2019 | 67 | 1.340 |
Why?
|
Mice, Inbred C57BL | 17 | 2019 | 711 | 1.300 |
Why?
|
Muscle Proteins | 11 | 2015 | 57 | 1.290 |
Why?
|
Calpain | 2 | 2017 | 12 | 1.170 |
Why?
|
Gene Expression Regulation | 13 | 2018 | 481 | 1.150 |
Why?
|
Caloric Restriction | 3 | 2019 | 92 | 1.140 |
Why?
|
Obesity | 4 | 2019 | 1063 | 1.130 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 14 | 2015 | 18 | 1.110 |
Why?
|
Muscle Cells | 2 | 2018 | 7 | 1.100 |
Why?
|
Mice, Transgenic | 15 | 2016 | 249 | 1.100 |
Why?
|
Excitation Contraction Coupling | 4 | 2015 | 8 | 1.100 |
Why?
|
Transcription, Genetic | 6 | 2018 | 136 | 1.040 |
Why?
|
Membrane Proteins | 6 | 2013 | 256 | 1.000 |
Why?
|
Muscular Atrophy | 10 | 2018 | 67 | 0.990 |
Why?
|
Regeneration | 3 | 2015 | 167 | 0.990 |
Why?
|
Myosin Heavy Chains | 5 | 2012 | 86 | 0.970 |
Why?
|
Green Fluorescent Proteins | 6 | 2014 | 71 | 0.930 |
Why?
|
Muscle Development | 4 | 2015 | 45 | 0.880 |
Why?
|
Physical Conditioning, Animal | 4 | 2017 | 32 | 0.840 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 68 | 0.830 |
Why?
|
Antigens | 5 | 2016 | 31 | 0.830 |
Why?
|
Proteoglycans | 5 | 2016 | 29 | 0.820 |
Why?
|
Muscles | 10 | 1993 | 53 | 0.820 |
Why?
|
Muscle Fatigue | 4 | 2016 | 11 | 0.800 |
Why?
|
Cells, Cultured | 11 | 2014 | 799 | 0.760 |
Why?
|
Ion Channel Gating | 7 | 2010 | 19 | 0.750 |
Why?
|
RNA, Messenger | 6 | 2013 | 514 | 0.740 |
Why?
|
Sulfonamides | 2 | 2017 | 65 | 0.740 |
Why?
|
Acute Lung Injury | 3 | 2015 | 30 | 0.740 |
Why?
|
Cell Line | 9 | 2018 | 449 | 0.730 |
Why?
|
Receptors, Cholinergic | 2 | 2018 | 21 | 0.730 |
Why?
|
Amyotrophic Lateral Sclerosis | 8 | 2007 | 62 | 0.710 |
Why?
|
Acetylcholine | 2 | 2018 | 47 | 0.700 |
Why?
|
Clenbuterol | 1 | 2019 | 2 | 0.690 |
Why?
|
Synaptic Potentials | 1 | 2019 | 3 | 0.690 |
Why?
|
Sympathomimetics | 1 | 2019 | 4 | 0.690 |
Why?
|
TRPV Cation Channels | 1 | 2019 | 19 | 0.680 |
Why?
|
Satellite Cells, Skeletal Muscle | 2 | 2015 | 8 | 0.680 |
Why?
|
Albuterol | 1 | 2019 | 40 | 0.680 |
Why?
|
Rats | 29 | 2004 | 1604 | 0.670 |
Why?
|
Sympathetic Nervous System | 1 | 2018 | 29 | 0.670 |
Why?
|
Ribonucleotide Reductases | 1 | 2018 | 6 | 0.650 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 48 | 0.630 |
Why?
|
Patch-Clamp Techniques | 11 | 2012 | 76 | 0.630 |
Why?
|
Neovascularization, Physiologic | 3 | 2016 | 106 | 0.620 |
Why?
|
Protein Phosphatase 1 | 1 | 2017 | 5 | 0.620 |
Why?
|
Intermediate Filament Proteins | 3 | 2012 | 9 | 0.620 |
Why?
|
Lipolysis | 1 | 2017 | 17 | 0.620 |
Why?
|
Central Nervous System | 2 | 2007 | 29 | 0.600 |
Why?
|
Humans | 40 | 2019 | 29093 | 0.590 |
Why?
|
Adipogenesis | 2 | 2015 | 26 | 0.590 |
Why?
|
DNA | 1 | 2018 | 204 | 0.580 |
Why?
|
Cell Differentiation | 7 | 2017 | 436 | 0.580 |
Why?
|
Membrane Potentials | 17 | 2013 | 80 | 0.580 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 118 | 0.580 |
Why?
|
Male | 24 | 2019 | 17807 | 0.570 |
Why?
|
Isometric Contraction | 5 | 2016 | 21 | 0.570 |
Why?
|
Glioblastoma | 2 | 2016 | 143 | 0.560 |
Why?
|
Cell Lineage | 5 | 2017 | 67 | 0.560 |
Why?
|
Wasting Syndrome | 2 | 2015 | 14 | 0.560 |
Why?
|
Muscle Denervation | 8 | 2017 | 28 | 0.550 |
Why?
|
Female | 20 | 2019 | 18164 | 0.540 |
Why?
|
Weight Loss | 2 | 2017 | 413 | 0.520 |
Why?
|
Aged | 14 | 2019 | 9487 | 0.520 |
Why?
|
Troponin | 1 | 2015 | 79 | 0.510 |
Why?
|
Quadriceps Muscle | 2 | 2012 | 31 | 0.510 |
Why?
|
Myogenin | 1 | 2014 | 4 | 0.500 |
Why?
|
Cicatrix | 1 | 2014 | 36 | 0.500 |
Why?
|
Neutrophils | 1 | 2015 | 102 | 0.500 |
Why?
|
Lipids | 1 | 2015 | 209 | 0.490 |
Why?
|
Myoblasts | 1 | 2014 | 38 | 0.490 |
Why?
|
Apoptosis | 2 | 2013 | 337 | 0.480 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 81 | 0.470 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 51 | 0.470 |
Why?
|
Knee Joint | 1 | 2015 | 129 | 0.470 |
Why?
|
Ischemia | 1 | 2014 | 92 | 0.470 |
Why?
|
Wound Healing | 1 | 2015 | 182 | 0.470 |
Why?
|
Exercise Tolerance | 1 | 2013 | 110 | 0.440 |
Why?
|
Exercise Therapy | 1 | 2015 | 229 | 0.440 |
Why?
|
Neuroglia | 1 | 2012 | 29 | 0.440 |
Why?
|
MicroRNAs | 1 | 2015 | 173 | 0.430 |
Why?
|
Brain Neoplasms | 2 | 2016 | 587 | 0.420 |
Why?
|
Promoter Regions, Genetic | 5 | 2016 | 212 | 0.410 |
Why?
|
Eating | 1 | 2012 | 73 | 0.400 |
Why?
|
Electrophysiology | 9 | 2007 | 66 | 0.400 |
Why?
|
Transgenes | 1 | 2011 | 45 | 0.390 |
Why?
|
Aged, 80 and over | 6 | 2019 | 3717 | 0.390 |
Why?
|
Muscle Weakness | 2 | 2009 | 39 | 0.380 |
Why?
|
Hindlimb | 5 | 2014 | 57 | 0.380 |
Why?
|
Biosensing Techniques | 1 | 2010 | 20 | 0.360 |
Why?
|
Mice, Inbred DBA | 6 | 2008 | 36 | 0.360 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2015 | 32 | 0.350 |
Why?
|
Luminescent Proteins | 3 | 2014 | 24 | 0.350 |
Why?
|
Receptors, Nicotinic | 4 | 1998 | 60 | 0.350 |
Why?
|
Spinal Cord | 4 | 2007 | 139 | 0.340 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 3 | 2004 | 18 | 0.340 |
Why?
|
Age Factors | 6 | 2017 | 1108 | 0.320 |
Why?
|
Energy Intake | 2 | 1998 | 120 | 0.320 |
Why?
|
Time Factors | 7 | 2015 | 2001 | 0.310 |
Why?
|
Receptor, IGF Type 1 | 2 | 1997 | 7 | 0.310 |
Why?
|
Flow Cytometry | 3 | 2013 | 171 | 0.310 |
Why?
|
Superoxide Dismutase | 1 | 2007 | 47 | 0.300 |
Why?
|
Diaphragm | 4 | 1993 | 46 | 0.300 |
Why?
|
Gene Expression | 4 | 2013 | 332 | 0.300 |
Why?
|
Immunoglobulin G | 6 | 1994 | 104 | 0.290 |
Why?
|
Aminophylline | 3 | 1993 | 7 | 0.290 |
Why?
|
Protein Binding | 2 | 2018 | 199 | 0.290 |
Why?
|
Mice, Knockout | 6 | 2015 | 425 | 0.270 |
Why?
|
Body Composition | 3 | 2015 | 365 | 0.260 |
Why?
|
Mice, Nude | 3 | 2016 | 276 | 0.260 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2005 | 45 | 0.250 |
Why?
|
Mutation | 1 | 2007 | 466 | 0.250 |
Why?
|
Electric Conductivity | 3 | 1999 | 10 | 0.250 |
Why?
|
Exercise | 3 | 2019 | 591 | 0.250 |
Why?
|
Motor Activity | 3 | 2015 | 310 | 0.250 |
Why?
|
Calcineurin | 1 | 2004 | 3 | 0.240 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 6 | 0.240 |
Why?
|
Fibrosis | 2 | 2015 | 102 | 0.240 |
Why?
|
Motor Cortex | 1 | 2003 | 12 | 0.240 |
Why?
|
Intracellular Membranes | 1 | 2003 | 10 | 0.240 |
Why?
|
Nifedipine | 6 | 1993 | 7 | 0.230 |
Why?
|
Stem Cell Transplantation | 2 | 2016 | 203 | 0.220 |
Why?
|
Rats, Inbred F344 | 5 | 2003 | 125 | 0.210 |
Why?
|
Action Potentials | 9 | 2017 | 174 | 0.210 |
Why?
|
Actins | 2 | 2014 | 52 | 0.210 |
Why?
|
Sarcopenia | 2 | 2012 | 53 | 0.200 |
Why?
|
Mice, Inbred Strains | 3 | 2006 | 43 | 0.200 |
Why?
|
Electroporation | 2 | 2011 | 14 | 0.190 |
Why?
|
Disease Models, Animal | 3 | 2014 | 980 | 0.190 |
Why?
|
Verapamil | 2 | 1993 | 7 | 0.190 |
Why?
|
Synaptic Transmission | 2 | 2018 | 113 | 0.190 |
Why?
|
Signal Transduction | 3 | 2015 | 666 | 0.190 |
Why?
|
Cell Survival | 3 | 2007 | 272 | 0.180 |
Why?
|
Rats, Wistar | 6 | 1996 | 84 | 0.180 |
Why?
|
Down-Regulation | 2 | 2017 | 143 | 0.170 |
Why?
|
Synaptic Vesicles | 1 | 2019 | 7 | 0.170 |
Why?
|
Genes, Reporter | 2 | 2013 | 37 | 0.170 |
Why?
|
Luciferases | 3 | 2004 | 27 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2013 | 60 | 0.170 |
Why?
|
Protein Subunits | 2 | 2009 | 34 | 0.170 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 172 | 0.170 |
Why?
|
Consensus Sequence | 1 | 2018 | 10 | 0.160 |
Why?
|
Recombinant Fusion Proteins | 2 | 2011 | 97 | 0.160 |
Why?
|
Models, Biological | 2 | 2017 | 373 | 0.160 |
Why?
|
Rats, Inbred Strains | 8 | 1991 | 45 | 0.160 |
Why?
|
Coculture Techniques | 2 | 2016 | 74 | 0.160 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 107 | 0.160 |
Why?
|
Protein Isoforms | 2 | 2012 | 56 | 0.160 |
Why?
|
Caffeine | 6 | 2003 | 31 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2017 | 35 | 0.150 |
Why?
|
Middle Aged | 7 | 2018 | 10829 | 0.150 |
Why?
|
Adult | 6 | 2018 | 8420 | 0.150 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 10 | 0.150 |
Why?
|
Tetanus Toxin | 2 | 2006 | 6 | 0.140 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2016 | 17 | 0.140 |
Why?
|
Protein Stability | 1 | 2016 | 26 | 0.140 |
Why?
|
Phenotype | 2 | 2016 | 629 | 0.140 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 73 | 0.140 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 7 | 0.140 |
Why?
|
Torque | 1 | 2015 | 19 | 0.140 |
Why?
|
Kinetics | 5 | 2011 | 205 | 0.130 |
Why?
|
Tetraethylammonium Compounds | 3 | 1993 | 4 | 0.130 |
Why?
|
Gene Library | 1 | 2015 | 9 | 0.130 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 9 | 0.130 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 8 | 0.130 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 21 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2015 | 19 | 0.130 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 16 | 0.130 |
Why?
|
Chemokines | 1 | 2015 | 35 | 0.130 |
Why?
|
Neurogenesis | 1 | 2015 | 14 | 0.130 |
Why?
|
Alternative Splicing | 1 | 2015 | 28 | 0.130 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 65 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Adult | 1 | 2015 | 55 | 0.130 |
Why?
|
Organ Specificity | 1 | 2014 | 77 | 0.130 |
Why?
|
Nerve Growth Factors | 2 | 2005 | 18 | 0.130 |
Why?
|
Stem Cells | 1 | 2017 | 292 | 0.130 |
Why?
|
Chromatin | 1 | 2014 | 19 | 0.120 |
Why?
|
RNA Splicing | 1 | 2013 | 8 | 0.120 |
Why?
|
Laryngeal Muscles | 1 | 2014 | 16 | 0.120 |
Why?
|
Rats, Inbred BN | 3 | 1998 | 32 | 0.120 |
Why?
|
Endoplasmic Reticulum | 2 | 2011 | 24 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 2 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 4 | 0.120 |
Why?
|
Collagen | 1 | 2014 | 217 | 0.120 |
Why?
|
Leucine Zippers | 1 | 2013 | 3 | 0.110 |
Why?
|
Nuclear Localization Signals | 1 | 2013 | 3 | 0.110 |
Why?
|
Annexin A5 | 1 | 2013 | 8 | 0.110 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1993 | 14 | 0.110 |
Why?
|
Calcium-Transporting ATPases | 1 | 1993 | 1 | 0.110 |
Why?
|
Overweight | 1 | 2015 | 256 | 0.110 |
Why?
|
Peptide Fragments | 2 | 2006 | 422 | 0.110 |
Why?
|
Malignant Hyperthermia | 1 | 2012 | 3 | 0.110 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 45 | 0.110 |
Why?
|
Isotonic Contraction | 1 | 2012 | 8 | 0.110 |
Why?
|
Myofibrils | 1 | 2012 | 10 | 0.110 |
Why?
|
Biopsy | 1 | 2013 | 241 | 0.110 |
Why?
|
Cachexia | 1 | 2012 | 6 | 0.110 |
Why?
|
Tetrodotoxin | 3 | 2005 | 10 | 0.110 |
Why?
|
Mutation, Missense | 1 | 2012 | 48 | 0.110 |
Why?
|
Databases, Protein | 1 | 2012 | 13 | 0.110 |
Why?
|
Genetic Markers | 1 | 2012 | 122 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 248 | 0.110 |
Why?
|
Adult Stem Cells | 1 | 2012 | 24 | 0.110 |
Why?
|
Species Specificity | 1 | 2012 | 84 | 0.110 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 35 | 0.110 |
Why?
|
Immunoblotting | 1 | 2011 | 50 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2012 | 99 | 0.100 |
Why?
|
4-Aminopyridine | 2 | 1991 | 6 | 0.100 |
Why?
|
Cell Compartmentation | 1 | 2011 | 3 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2013 | 179 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 81 | 0.100 |
Why?
|
Subcellular Fractions | 1 | 2011 | 14 | 0.100 |
Why?
|
Leptin | 1 | 2012 | 66 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2011 | 56 | 0.100 |
Why?
|
Proteomics | 1 | 2012 | 92 | 0.100 |
Why?
|
Inflammation | 1 | 2015 | 507 | 0.100 |
Why?
|
Linear Models | 1 | 2012 | 426 | 0.100 |
Why?
|
North Carolina | 1 | 2015 | 1423 | 0.100 |
Why?
|
Hippocampus | 1 | 2012 | 185 | 0.090 |
Why?
|
Osmolar Concentration | 2 | 2003 | 17 | 0.090 |
Why?
|
Cresols | 1 | 2010 | 1 | 0.090 |
Why?
|
Recombinant Proteins | 2 | 2004 | 248 | 0.090 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 162 | 0.090 |
Why?
|
Body Weight | 1 | 2012 | 290 | 0.090 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 82 | 0.090 |
Why?
|
Insulin | 1 | 2012 | 346 | 0.090 |
Why?
|
Cytosol | 1 | 2009 | 25 | 0.090 |
Why?
|
Isradipine | 2 | 1999 | 2 | 0.090 |
Why?
|
Treatment Outcome | 1 | 2017 | 3099 | 0.090 |
Why?
|
Base Sequence | 2 | 2002 | 240 | 0.090 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 350 | 0.090 |
Why?
|
Ruthenium | 1 | 1989 | 1 | 0.090 |
Why?
|
Ruthenium Red | 1 | 1989 | 1 | 0.090 |
Why?
|
Membranes | 1 | 2008 | 11 | 0.080 |
Why?
|
Ions | 1 | 2008 | 11 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2012 | 519 | 0.080 |
Why?
|
Capillaries | 1 | 2008 | 23 | 0.080 |
Why?
|
Theophylline | 1 | 1988 | 4 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2013 | 2108 | 0.080 |
Why?
|
Cyclic AMP | 1 | 1988 | 40 | 0.080 |
Why?
|
Respiratory Muscles | 1 | 1987 | 7 | 0.080 |
Why?
|
Aminopyridines | 1 | 1987 | 7 | 0.080 |
Why?
|
Xanthenes | 1 | 2007 | 4 | 0.080 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2007 | 7 | 0.080 |
Why?
|
Calcium Channel Blockers | 3 | 1999 | 49 | 0.080 |
Why?
|
Stress, Mechanical | 1 | 2008 | 90 | 0.080 |
Why?
|
Aniline Compounds | 1 | 2007 | 25 | 0.080 |
Why?
|
Organ Size | 2 | 2007 | 196 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 532 | 0.080 |
Why?
|
Glycine | 1 | 2007 | 25 | 0.080 |
Why?
|
Cell Size | 1 | 2007 | 32 | 0.080 |
Why?
|
Protein Kinase C | 2 | 1997 | 37 | 0.080 |
Why?
|
Alanine | 1 | 2007 | 27 | 0.080 |
Why?
|
Longevity | 1 | 2007 | 22 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 45 | 0.080 |
Why?
|
Dihydropyridines | 3 | 1997 | 3 | 0.080 |
Why?
|
Nicotinic Agonists | 2 | 1998 | 48 | 0.080 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2006 | 6 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 2 | 1999 | 747 | 0.070 |
Why?
|
Phosphorylation | 2 | 1997 | 225 | 0.070 |
Why?
|
Injections | 1 | 2006 | 61 | 0.070 |
Why?
|
Nicotine | 3 | 1998 | 157 | 0.070 |
Why?
|
Models, Neurological | 1 | 2007 | 115 | 0.070 |
Why?
|
Thymidine | 1 | 2005 | 7 | 0.070 |
Why?
|
Ryanodine | 2 | 2015 | 3 | 0.070 |
Why?
|
Sodium Channels | 1 | 2005 | 13 | 0.070 |
Why?
|
Potassium | 3 | 1990 | 37 | 0.060 |
Why?
|
Fura-2 | 2 | 1995 | 4 | 0.060 |
Why?
|
Anesthetics, Local | 1 | 2005 | 77 | 0.060 |
Why?
|
Cell Membrane | 2 | 2006 | 97 | 0.060 |
Why?
|
Transfection | 2 | 2002 | 192 | 0.060 |
Why?
|
Electric Stimulation | 2 | 1999 | 102 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 1984 | 38 | 0.060 |
Why?
|
Efferent Pathways | 1 | 2003 | 8 | 0.060 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2003 | 14 | 0.060 |
Why?
|
Electromyography | 1 | 2004 | 58 | 0.060 |
Why?
|
Pyramidal Cells | 1 | 2003 | 15 | 0.060 |
Why?
|
Extremities | 1 | 2003 | 48 | 0.060 |
Why?
|
Cholinesterases | 1 | 2003 | 10 | 0.060 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 5 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2002 | 74 | 0.060 |
Why?
|
Apamin | 2 | 1993 | 2 | 0.050 |
Why?
|
Tetraethylammonium | 2 | 1993 | 3 | 0.050 |
Why?
|
SOXD Transcription Factors | 1 | 2002 | 1 | 0.050 |
Why?
|
Nuclease Protection Assays | 1 | 2002 | 2 | 0.050 |
Why?
|
GATA4 Transcription Factor | 1 | 2002 | 2 | 0.050 |
Why?
|
Plasmids | 1 | 2002 | 48 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2002 | 30 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2002 | 71 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 142 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2001 | 21 | 0.050 |
Why?
|
DNA Probes | 1 | 2001 | 17 | 0.050 |
Why?
|
Rabbits | 2 | 2006 | 185 | 0.050 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2000 | 3 | 0.050 |
Why?
|
Aconitine | 2 | 1998 | 5 | 0.050 |
Why?
|
Transcription Factors | 1 | 2002 | 172 | 0.050 |
Why?
|
Reaction Time | 1 | 2001 | 121 | 0.050 |
Why?
|
Intracellular Fluid | 1 | 2000 | 2 | 0.050 |
Why?
|
Biophysics | 1 | 2000 | 9 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2000 | 6 | 0.050 |
Why?
|
Algorithms | 1 | 2003 | 462 | 0.050 |
Why?
|
Intracellular Space | 1 | 1999 | 16 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 1 | 1999 | 24 | 0.050 |
Why?
|
Foot | 1 | 1999 | 40 | 0.040 |
Why?
|
RNA, Antisense | 1 | 1999 | 3 | 0.040 |
Why?
|
Animals, Newborn | 1 | 1999 | 111 | 0.040 |
Why?
|
Food Deprivation | 1 | 1998 | 3 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 1984 | 518 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1998 | 23 | 0.040 |
Why?
|
Body Mass Index | 2 | 2015 | 865 | 0.040 |
Why?
|
Nicotinic Antagonists | 1 | 1998 | 19 | 0.040 |
Why?
|
Molecular Weight | 1 | 1997 | 40 | 0.040 |
Why?
|
Egtazic Acid | 1 | 1997 | 3 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 1997 | 51 | 0.040 |
Why?
|
Receptor Aggregation | 1 | 1997 | 1 | 0.040 |
Why?
|
Genistein | 1 | 1997 | 14 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.040 |
Why?
|
Analysis of Variance | 1 | 1998 | 454 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 82 | 0.040 |
Why?
|
Isoflavones | 1 | 1997 | 65 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 113 | 0.040 |
Why?
|
Cell Separation | 1 | 2016 | 86 | 0.030 |
Why?
|
Biological Transport | 1 | 1995 | 62 | 0.030 |
Why?
|
Ion Transport | 1 | 1995 | 5 | 0.030 |
Why?
|
Cell Movement | 1 | 2016 | 161 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1995 | 89 | 0.030 |
Why?
|
Glycogen Phosphorylase | 1 | 2015 | 2 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2015 | 16 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1995 | 12 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1997 | 641 | 0.030 |
Why?
|
Nervous System Diseases | 2 | 1994 | 37 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 680 | 0.030 |
Why?
|
Vocal Cords | 1 | 2014 | 8 | 0.030 |
Why?
|
Purkinje Cells | 1 | 1993 | 2 | 0.030 |
Why?
|
Cerebellar Cortex | 1 | 1993 | 4 | 0.030 |
Why?
|
Neurotoxins | 1 | 1993 | 16 | 0.030 |
Why?
|
Antibodies | 1 | 1994 | 53 | 0.030 |
Why?
|
Sarcomeres | 1 | 1993 | 2 | 0.030 |
Why?
|
Drug Interactions | 1 | 1993 | 80 | 0.030 |
Why?
|
Manganese | 1 | 2013 | 10 | 0.030 |
Why?
|
Sciatic Nerve | 1 | 1993 | 35 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 67 | 0.030 |
Why?
|
Hot Temperature | 1 | 1993 | 71 | 0.030 |
Why?
|
Diet | 1 | 2015 | 354 | 0.030 |
Why?
|
Gene Frequency | 1 | 2012 | 225 | 0.030 |
Why?
|
RING Finger Domains | 1 | 2012 | 2 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2012 | 67 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 80 | 0.030 |
Why?
|
Cadmium | 1 | 1991 | 8 | 0.030 |
Why?
|
Random Allocation | 1 | 2012 | 213 | 0.030 |
Why?
|
Blotting, Western | 1 | 2012 | 281 | 0.020 |
Why?
|
Reference Values | 1 | 1991 | 224 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 1990 | 8 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 637 | 0.020 |
Why?
|
Mammals | 1 | 1989 | 9 | 0.020 |
Why?
|
Solutions | 1 | 1987 | 26 | 0.020 |
Why?
|
Dactinomycin | 1 | 1986 | 10 | 0.020 |
Why?
|
Calsequestrin | 1 | 2006 | 2 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 95 | 0.020 |
Why?
|
Gene Silencing | 1 | 2006 | 49 | 0.020 |
Why?
|
Polyamines | 2 | 1995 | 10 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 1995 | 50 | 0.020 |
Why?
|
Dogs | 1 | 1984 | 117 | 0.010 |
Why?
|
Dimethylphenylpiperazinium Iodide | 1 | 1998 | 1 | 0.010 |
Why?
|
Bungarotoxins | 1 | 1998 | 2 | 0.010 |
Why?
|
Benzylidene Compounds | 1 | 1998 | 6 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1998 | 18 | 0.010 |
Why?
|
Insecticides | 1 | 1998 | 21 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 81 | 0.010 |
Why?
|
Binding Sites | 1 | 1998 | 125 | 0.010 |
Why?
|
Pyridines | 1 | 1998 | 78 | 0.010 |
Why?
|
Up-Regulation | 1 | 1998 | 183 | 0.010 |
Why?
|
Ionophores | 1 | 1994 | 5 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1993 | 12 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 1993 | 6 | 0.010 |
Why?
|
Kidney | 1 | 1998 | 485 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 152 | 0.010 |
Why?
|
Myasthenia Gravis | 1 | 1993 | 9 | 0.010 |
Why?
|